Document › Details

Bionow (The Centre of Excellence for Life Sciences Ltd. trading as Bionow). (8/1/12). "Press Release: Bionow Secures New Bio-incubator Project with Jingsui Life Science and Technology Park in Nanjing, China".

Region Region Nanjing
  Country China
Organisations Organisation Centre of Excellence for Life Sciences Ltd., The (trading as Bionow)
  Group Bionow (Group)
  Organisation 2 Jingsu Life Science and Technology Park
Products Product business park management / science park management
  Product 2 LIFE SCIENCES
     


Bionow has secured a contract to partner with Jingsu Life Science and Technology Park, in the Qixia district of Nanjing city, to design and deliver services to support UK life science and biomedical companies locating into a new 10,000 square metre bio-incubator in this important region of China.

At an official ceremony in London last week, Bionow's Executive Director Mike Nicholds, Jingsu Life Science and Technology Park Deputy Director Mr Dou Lihua and Dr Wanzhou Zhao of OG Pharma signed an agreement marking the start of this innovative project. Bionow has been working with its partners in Nanjing for over 12 months to develop a "bridge" for companies wanting to enter and collaborate in the rapidly growing biomedical market in China. Bionow will advise on the design of the physical infrastructure and importantly on the "bio-incubator" support services necessary to ensure SME's from the UK can have the confidence that their operations will be successful. Construction of the bio-incubator is already well advanced with a completion date for the six-storey facility set for autumn 2012.

China is undergoing major healthcare reform and the pharmaceutical and biomedical market is forecast to grow to $35bn by 2015. Nanjing has the largest number of professionals in life sciences and biotechnology in China and over 20,000 students studying in life sciences. The city and surrounding region is home to 15 national laboratories and institutions, 70 pharmaceutical companies and over 200 medical device companies. In 2011, the city's biomedical industry grew its turnover by 40% to £5.1bn and investment will continue in the Biomedical Valley including £300m into the science park that hosts the bio-incubator.

The project is led in the UK by Dr Kenny Lang, Business Development Associate at Bionow and Science and Technology consultant to Nanjing Municipal Science and Technology Bureau. Dr Lang has extensive experience of current best practice in bio-incubation facilities and services from working at the Babraham Research Campus in Cambridge and on projects in the North of England.

Bionow Executive Director, Dr Mike Nicholds commented "The signing of this agreement is the start of partnership with a key life science cluster in the rapidly growing Chinese market. We have a mutual aim of creating a "bio-bridge" in-line with the broader UK strategy to not only create the right supportive environment for UK life science companies to thrive in China but also to promote a two-way flow of collaboration and investment into the UK"

For further information please contact Kenny Lang via the contact details here [ http://www.bionow.co.uk/aboutbionow/theteam.aspx ]

   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for Bionow (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] – Putting Information into Context 600x60px




» top